Navigation Links
Potential vaccine developed for deadly leishmaniasis disease

rm," Seeberger said. "Therefore, this is a proof-of-principle study that will be applicable to many carbohydrate antigens of importance in other diseases as well," he said. Seeberger cited both infectious and parasitic diseases and vaccines against cancer.

WHO assigned a high priority to development of a leishmaniasis vaccine because of the huge human toll and the lack of any effective treatment. The most common drugs used to treat leishmaniasis have serious side effects and are expensive.

Symptoms of visceral leishmaniasis include fever, weight loss, and abnormalities of the liver and spleen.


'"/>

Source:American Chemical Society


Page: 1 2 3

Related biology news :

1. Novel Enzyme Shows Potential As An Anti-HIV Target
2. Potential Cure for Lymphoma in HIV patients
3. Potential treatments for neurofibromatosis
4. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
5. Potential Drug Target For Treating Cocaine Abuse Found
6. Potential heart benefit found in stem cells
7. Research advances quest for HIV-1 vaccine
8. A much-needed shot in the arm for HIV vaccine development
9. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
10. Gene vaccine for Alzheimers disease shows promising results
11. Influenza vaccine uses insect cells to speed development
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Potential vaccine developed for deadly leishmaniasis disease

(Date:8/24/2015)... The consulting company Frost & Sullivan ... DERMALOG and its customized solutions and products for ... the Year Award". DERMALOG is particularly successful with a large ... -Cross reference: Picture is available at AP Images ( ... Thursday evening, in South Africa,s economic ...
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... has joined The Smart Card Alliance and the EMV ... Alliance and the Smart Card Alliance Latin America (SCALA) ... industry peers and thought leaders promoting adoption of smart ...
(Date:8/17/2015)... OXFORD, Conn. , Aug. 17, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces its new sales campaign for Q4 2015. The ... winning marketing team consisting of Amplitude Marketing Group ( ... Amplitude Marketing Group is a leader in retail driven ...
Breaking Biology News(10 mins):Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
... -- A team of researchers from The Florida State ... will study the environmental and economic impacts of the ... on shrimping in the region, home to one of ... State will serve as the lead institution for the ...
... Oct. 30 SCM Microsystems, Inc. (Nasdaq: SCMM ) ... access, secure identity and secure exchange, announced today that its ... shares authorized during yesterday,s annual meeting of stockholders. ... 61 percent of SCM,s stockholders cast their votes and a ...
... The North Pacific Ocean is now commonly referred to ... size of the continental United States covered in plastic debris. ... forages throughout the North Pacific, is quickly becoming the poster ... due to their tendency to ingest large amounts of plastic. ...
Cached Biology News:FSU, Duke partner to study impact of Gulf's 'dead zone' on shrimp fishery 2FSU, Duke partner to study impact of Gulf's 'dead zone' on shrimp fishery 3SCM Microsystems Announces Results of Annual Meeting 2Dining out in an ocean of plastic: How foraging albatrosses put plastic on the menu 2
(Date:8/27/2015)... Greifensee, Switzerland (PRWEB) , ... August 27, 2015 ... ... input on customers’ weighing needs and expertly narrows down the product choices to ... additional selection criteria pares down the list to models that fit best with ...
(Date:8/26/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended June 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Oral Amp B program, rapidly advancing towards the ... Rae , President & CEO of iCo Therapeutics. "We ...
(Date:8/26/2015)... Aug. 26, 2015  Platform therapeutic company Symic ... received a $1.5M Phase II SBIR grant from ... develop its therapeutic agent to reduce arteriovenous fistula ... end stage renal disease (ESRD) patients undergoing hemodialysis. ... of Diabetes and Digestive and Kidney Diseases (NIDDK), ...
(Date:8/26/2015)... 2015 After litigating and negotiating patent ... to P2i United States patent RE43,651 ... the United States without any admission ... either party. As a result of the parties, settlement, the ... California dismissed the case without prejudice. ...
Breaking Biology Technology:METTLER TOLEDO Updates Online Scale Selection Tool 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3P2i Settles United States Litigation 2
... 28 Entest BioMedical, Inc., a newly formed wholly-owned ... Bulletin Board: BMSN) announced today the launch of its ... to focus on new stem cell research, including a ... traumatic brain injury (TBI) using autologous adipose-derived (fat) stem ...
... ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF ), ... solutions, announced today that VWR International, LLC (VWR) has ... Chester, Pennsylvania, VWR is a global laboratory supply and ... billion. , "The U.S. is an important market for ...
... Diagnostics scientists will present results of three studies revealing ... treatment of chronic myeloid leukemia (CML) and prostate cancer ... of Clinical Oncology (ASCO), scheduled for May 29 through ... DGX ) is the world,s leading provider ...
Cached Biology Technology:New Stem Cell Web Site to Focus on Traumatic Brain Injury, Spinal Cord Injury and Diabetes 2MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 2Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 3Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 4Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting 5
...
...
...
... and Sartolab P20 plus,for Reliable Sterile Filtration ... attached to a,membrane pump or tube pump, ... liter of media,and aqueous solutions. The ... and an automatic de-aeration,ensures high flow rates ...
Biology Products: